Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
154.68
-3.26 (-2.06%)
At close: Mar 28, 2025, 4:00 PM
149.74
-4.94 (-3.19%)
Pre-market: Mar 31, 2025, 8:45 AM EDT
Ascendis Pharma Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$201.79
Upside
+30.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $168 → $200 | Buy | Maintains | $168 → $200 | +29.30% | Mar 18, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $170 → $200 | Buy | Maintains | $170 → $200 | +29.30% | Feb 25, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $220 → $260 | Buy | Maintains | $220 → $260 | +68.09% | Feb 18, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $200 → $225 | Strong Buy | Maintains | $200 → $225 | +45.46% | Feb 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $167 → $168 | Buy | Maintains | $167 → $168 | +8.61% | Feb 13, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | +9.90% | Feb 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $165 → $167 | Buy | Maintains | $165 → $167 | +7.96% | Jan 29, 2025 |
| UBS | UBS | Strong Buy Initiates $196 | Strong Buy | Initiates | $196 | +26.71% | Jan 7, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $160 → $153 | Strong Buy | Maintains | $160 → $153 | -1.09% | Nov 15, 2024 |
| Wedbush | Wedbush | Buy Reiterates $181 | Buy | Reiterates | $181 | +17.02% | Nov 15, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $190 → $180 | Buy | Maintains | $190 → $180 | +16.37% | Nov 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | +9.90% | Nov 15, 2024 |
| Stifel | Stifel | Strong Buy Maintains $200 → $207 | Strong Buy | Maintains | $200 → $207 | +33.82% | Nov 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | +9.90% | Nov 4, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $180 → $174 | Buy | Maintains | $180 → $174 | +12.49% | Oct 23, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $157 → $160 | Strong Buy | Maintains | $157 → $160 | +3.44% | Oct 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.